![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Significant unmet need for a treatment for cold agglutinin disease, a chronic rare blood disease that can result in life-threatening events like stroke BIVV009 granted breakthrough...
IPG Photonics Set to Join S&P 500; ALLETE and LendingTree to Join S&P MidCap 400; New York Mortgage Trust, Global Net Lease and Finisar to Join S&P SmallCap 600 PR Newswire NEW YORK...
By Sonia Amaral Rohter Sanofi SA (SAN.FR) said on Friday that a U.S. waiting period for its proposed acquisition of Bioverativ Inc. (BIVV) has expired without objections. With the expiration...
Bioverativ Inc. (NASDAQ: BIVV), a global biopharmaceutical company dedicated to transforming the lives of people with rare blood disorders, today announced the publication of a...
Full year 2017 year-over-year revenues up 31.7% Fourth quarter revenues up 28.3% year-over-year Full year 2017 GAAP operating margin of 38.3%; Non-GAAP operating margin of 46.5...
WeissLaw LLP Investigates Bioverativ Inc. Acquisition PR Newswire NEW YORK, Jan. 24, 2018 NEW YORK, Jan. 24, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty...
By Jonathan D. Rockoff This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (January 23...
By Jonathan D. Rockoff Big drugmakers, searching for new sources of revenue, are paying hefty premiums for biotechnology businesses, with two multibillion-dollar acquisitions announced Monday...
By Jonathan D. Rockoff A pair of multibillion-dollar biotech deals announced Monday commanded hefty premiums, driven by big drugmakers' need for new sources of revenue amid a scarcity of...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Bioverativ Inc. PR Newswire NEW YORK, Jan. 22, 2018 NEW YORK, Jan. 22, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions